Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fastenal Company Common Stock (FAST) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Fastenal Company Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Fastenal Company Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Fastenal Company Common Stock trades at $52.13 (market cap $59.02B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Fastenal Company Common Stock is far larger — about 32.8× Vir Biotechnology Inc. Common Stock's market cap, and Fastenal Company Common Stock pays a 1.87% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fastenal Company Common Stock for 2 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

FASTVIR
Market Cap
$59.02B$1.80B
Volume
10,054,9111,782,836
Sector
IndustrialsHealth
52-Week High
$52.38$11.78
52-Week Low
$39.15$5.12
Typical Hold Time
2 Days0 Days
Enterprise Value
$59.25B$1.36B
Dividend Yield
1.87%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fastenal Company Common Stock

Fastenal (FAST) trades at $51.43, down 0.12% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with Q3 2026 earnings of $0.35 per share beating estimates, marking the fourth consecutive quarterly beat. Revenue grew 15.5% year-over-year to $2.46 billion, driven by market share gains and new contract wins. The stock shows resilience with consistent operational performance despite premium valuation metrics.

Outlook remains positive with strong industrial demand and digital initiatives supporting growth, though the elevated P/E ratio of 43.96 presents valuation risk. Analyst consensus leans cautious with 59% hold ratings, suggesting limited near-term upside from current levels. Key risks include economic sensitivity and competitive pressures in industrial distribution.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FAST
100% Buy0% Sell
Avg holding period · 2 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Fastenal Company Common Stock

Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.

Read more on FAST →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →